시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
RWE(Real-World Evidence) 분석 시장 규모, 점유율, 성장 분석 : 구성요소별, 용도별, 수익 모델별, 전개 방식별, 지역별 - 산업 예측(2025-2032년)
Real World Evidence Analytics Market Size, Share, Growth Analysis, By Component, By Application, By Revenue Model, By Deployment Mode, By Region - Industry Forecast 2025-2032
상품코드 : 1623956
리서치사 : SkyQuest
발행일 : 2025년 01월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,657,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,957,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,258,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

RWE(Real-World Evidence) 분석 세계 시장 규모는 2023년 24억 달러로 평가되며, 2024년 25억 9,000만 달러에서 2032년 48억 4,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 8.1%의 CAGR을 기록할 것으로 예상됩니다.

이 보고서는 상환 결정, 의약품 개발, 시판 후 조사, 임상 규제 프로세스 등 다양한 분야에 필수적인 리얼월드에비던스(RWE) 분석 솔루션의 신흥국 시장을 분석합니다. RWE 분석 솔루션의 주요 최종사용자는 제약, 생명공학, 의료기기, 의료기기 회사, 의료 지불자, 의료 서비스 제공자 등 다양하며, RWE 분석 시장은 헬스케어 빅데이터의 급증, 가치 기반 치료로의 전환, 맞춤형 의료에 대한 관심으로 인해 활성화되고 있습니다. 활성화되고 있습니다. 데이터의 복잡성과 양이 증가함에 따라 RWE 프로그램에 효과적인 기술 통합이 시급히 요구되고 있습니다. 이에 따라 많은 조직들이 속도, 유연성, 보안, 확장성을 갖춘 클라우드 기술을 활용하여 환자 데이터를 보호하고 인사이트 창출을 가속화하기 위해 클라우드 기술을 활용하고 있습니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

RWE(Real-World Evidence) 분석 시장 규모 : 구성요소별

RWE(Real-World Evidence) 분석 시장 규모 : 용도별

RWE(Real-World Evidence) 분석 시장 규모 : 수익 모델별

RWE(Real-World Evidence) 분석 시장 규모 : 전개 방식별

RWE(Real-World Evidence) 분석 시장 규모 : 최종사용자별

RWE(Real-World Evidence) 분석 시장 규모

경쟁 정보

주요 기업 개요

결론과 추천사항

ksm
영문 목차

영문목차

Global Real World Evidence Analytics Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.59 billion in 2024 to USD 4.84 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The report analyzes the growing market for Real-World Evidence (RWE) analytics solutions, which are essential for various applications including reimbursement decisions, drug development, post-market surveillance, and clinical regulatory processes. Key end-users of these solutions span pharmaceutical, biotechnology, medical device companies, healthcare payers, and providers. The RWE analytics market is being fueled by the surge of big data in healthcare, a shift towards value-based care, and a focus on personalized medicine. As data complexity and volume increase, there is a pressing need for effective technology integration in RWE programs. Consequently, many organizations are leveraging cloud technologies for their speed, flexibility, security, and scalability, which enhances patient data protection and accelerates insight generation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Real World Evidence Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Real World Evidence Analytics Market Segmental Analysis

Global Real World Evidence Analytics Market is segmented by Component, Application, Revenue Model, Deployment Mode, End User and region. Based on Component, the market is segmented into Services and Data Sets. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Post-Market Surveillance, Market Access & Reimbursement/Coverage Decision-Making and Clinical & Regulatory Decision-Making. Based on Revenue Model, the market is segmented into Pay Per Use (Value-Based Pricing) and Subscription. Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. Based on End User, the market is segmented into Pharmaceutical & Medical Device Companies, Healthcare Payers, Healthcare Providers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Real World Evidence Analytics Market

The Global Real World Evidence Analytics market is significantly driven by the increasing elderly population, which correlates with a higher incidence of chronic diseases. This demographic trend is prompting a transition from volume-based care to value-based care models. Additionally, prolonged drug development timelines and rising costs are fueling the demand for effective RWE solutions. Moreover, enhanced research and development expenditures, alongside robust support from regulatory authorities for the adoption of real-world evidence methodologies, are further contributing to the market's expansion. Collectively, these factors are pivotal in shaping the growth trajectory of the Real World Evidence Analytics sector.

Restraints in the Global Real World Evidence Analytics Market

A major challenge facing the Global Real World Evidence Analytics market is the absence of universally accepted methodological standards and robust data processing infrastructure. This void in established guidelines for designing, conducting, analyzing, and reporting Real World Evidence (RWE) leads to skepticism about its quality and reliability. Consequently, RWE often fails to be recognized as credible enough to inform comparisons of treatment efficacy, which undermines its potential value and decreases motivation for its generation. Furthermore, this situation dissuades key stakeholders from engaging with RWE, stifling innovation and progress within the industry as a whole.

Market Trends of the Global Real World Evidence Analytics Market

The Global Real World Evidence (RWE) Analytics market is poised for significant growth as artificial intelligence (AI) becomes integral to enhancing data standards and quality control. AI applications are revolutionizing the pre-processing of real-world data (RWD), enabling pharmaceutical and biotechnology companies to accelerate insights and maximize the utility of diverse data sources. This trend is underscored by the emergence of advanced RWE technology platforms offering intelligent data processing and analysis capabilities. By leveraging AI innovations, stakeholders can improve drug research and patient outcomes while uncovering new business opportunities, ultimately fostering a more efficient and responsive healthcare ecosystem.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Real World Evidence Analytics Market Size by Component & CAGR (2025-2032)

Global Real World Evidence Analytics Market Size by Application & CAGR (2025-2032)

Global Real World Evidence Analytics Market Size by Revenue Model & CAGR (2025-2032)

Global Real World Evidence Analytics Market Size by Deployment Mode & CAGR (2025-2032)

Global Real World Evidence Analytics Market Size by End User & CAGR (2025-2032)

Global Real World Evidence Analytics Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기